Message-ID: <27719105.1075855881829.JavaMail.evans@thyme> Date: Tue, 19 Sep 2000 05:14:00 -0700 (PDT) From: david.maxwell@enron.com To: shona.wilson@enron.com Subject: Genoil addition to MPR Cc: sally.beck@enron.com, ted.murphy@enron.com Mime-Version: 1.0 Content-Type: text/plain; charset=us-ascii Content-Transfer-Encoding: 7bit Bcc: sally.beck@enron.com, ted.murphy@enron.com X-From: David Maxwell X-To: Shona Wilson X-cc: Sally Beck, Ted Murphy X-bcc: X-Folder: \Sally_Beck_Dec2000\Notes Folders\Mpr X-Origin: Beck-S X-FileName: sbeck.nsf Shona We have had issues in the past with Canada not informing us of all of their Merchant investments. For six months we chased Invasion Debt and finally received enough information to put it on the MPR in August (only after it was placed in Raptor I). Also, about six months ago, John Lavorato asked about an asset called CNR Warrants that showed up on the "hot list" but we were told by Canada that they were going to sell it so they did not want it on the MPR. Today, we were told that Kyle Kitagawa wanted to sell an asset called Genoil (approx. 4.7 million shares). Again, we did not know that they owned this investment. We have contacted Donna Lowry about Genoil because Beau Canada is on the restricted list and think Genoil would be, too. A trip to Canada may be necessary in order to reinforce our full disclosure policies regarding the MPR. Please let me know if I can provide any additional information. David M. ---------------------- Forwarded by David Maxwell/HOU/ECT on 09/19/2000 11:45 AM --------------------------- From: Derek Lynn 09/19/2000 11:44 AM To: David Maxwell/HOU/ECT@ECT, Adarsh Vakharia/HOU/ECT@ECT cc: Kyle Kitagawa/CAL/ECT@ECT, Jai Hawker Subject: Genoil addition to MPR As a result of a distribution from Beau Canada Exploration Inc. to its shareholders JEDI I now owns 4,666,667 Genoil Inc. shares (ticker GNO on the Toronto Stock Exchange) in addition to 7,000,000 Beau Canada Exploration shares. Beau Canada owned an interest in Genoil Inc.. In August Beau announced that it was going to distribute its ownership in Genoil to Beau shareholders. Each Beau Canada shareholder received 2/3 of a Genoil share for each Beau share.